Interleukin-13 augments transforming growth factor-beta1-induced tissue inhibitor of metalloproteinase-1 expression in primary human airway fibroblasts.
Zhou
XiuXia
X
National Jewish Medical and Research Center, and University of Colorado Health Sciences Center, Denver, Colorado 80206, USA. zhoux@njc.org
Trudeau
John B
JB
Schoonover
Kathryn J
KJ
Lundin
Jessica I
JI
Barnes
Steve M
SM
Cundall
Meghan J
MJ
Wenzel
Sally E
SE
D019870:1-Phosphatidylinositol 4-Kinase / Q000378:metabolism; D002478:Cells, Cultured; D004357:Drug Synergism; D004797:Enzyme-Linked Immunosorbent Assay; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism*; D006801:Humans; D018793:Interleukin-13 / Q000378:metabolism / Q000494:pharmacology*; D008168:Lung / Q000502:physiology; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000096:biosynthesis* / Q000187:drug effects; D016212:Transforming Growth Factor beta / Q000378:metabolism / Q000494:pharmacology*
D018793:Interleukin-13; D012333:RNA, Messenger; D019715:Tissue Inhibitor of Metalloproteinase-1; D016212:Transforming Growth Factor beta; D019870:1-Phosphatidylinositol 4-Kinase